SG Capital Management LLC purchased a new position in CBIZ, Inc. (NYSE:CBZ - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 251,044 shares of the business services provider's stock, valued at approximately $20,543,000. CBIZ accounts for about 2.0% of SG Capital Management LLC's portfolio, making the stock its 15th largest holding. SG Capital Management LLC owned approximately 0.50% of CBIZ as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also modified their holdings of the company. Royal Bank of Canada grew its holdings in shares of CBIZ by 7.4% in the 4th quarter. Royal Bank of Canada now owns 207,806 shares of the business services provider's stock worth $17,004,000 after acquiring an additional 14,310 shares during the period. ProShare Advisors LLC grew its holdings in shares of CBIZ by 49.2% in the 4th quarter. ProShare Advisors LLC now owns 13,497 shares of the business services provider's stock worth $1,104,000 after acquiring an additional 4,448 shares during the period. Man Group plc acquired a new stake in shares of CBIZ in the 4th quarter worth approximately $968,000. Nuveen Asset Management LLC grew its holdings in shares of CBIZ by 85.6% in the 4th quarter. Nuveen Asset Management LLC now owns 244,080 shares of the business services provider's stock worth $19,973,000 after acquiring an additional 112,569 shares during the period. Finally, Numerai GP LLC acquired a new stake in shares of CBIZ in the 4th quarter worth approximately $1,001,000. Institutional investors and hedge funds own 87.44% of the company's stock.
Insiders Place Their Bets
In other CBIZ news, Director Benaree Pratt Wiley sold 6,526 shares of the stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $71.75, for a total transaction of $468,240.50. Following the transaction, the director now owns 41,759 shares of the company's stock, valued at $2,996,208.25. This represents a 13.52% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Corporate insiders own 4.95% of the company's stock.
Analyst Ratings Changes
CBZ has been the topic of a number of analyst reports. William Blair reiterated an "outperform" rating on shares of CBIZ in a report on Friday, April 25th. StockNews.com cut CBIZ from a "hold" rating to a "sell" rating in a report on Tuesday, February 25th.
View Our Latest Analysis on CBIZ
CBIZ Price Performance
NYSE:CBZ traded up $0.07 during trading hours on Monday, reaching $74.20. 194,920 shares of the company traded hands, compared to its average volume of 346,164. The firm's 50-day moving average is $73.25 and its 200-day moving average is $78.49. The stock has a market cap of $4.04 billion, a P/E ratio of 31.44 and a beta of 0.91. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.49 and a quick ratio of 1.49. CBIZ, Inc. has a 1-year low of $62.66 and a 1-year high of $90.13.
CBIZ (NYSE:CBZ - Get Free Report) last issued its quarterly earnings results on Thursday, April 24th. The business services provider reported $2.29 earnings per share for the quarter, topping analysts' consensus estimates of $2.11 by $0.18. CBIZ had a return on equity of 15.12% and a net margin of 7.08%. The company had revenue of $838.01 million for the quarter, compared to analyst estimates of $860.25 million. During the same quarter in the prior year, the company posted $1.54 EPS. The business's revenue for the quarter was up 69.5% compared to the same quarter last year. Equities research analysts expect that CBIZ, Inc. will post 2.65 earnings per share for the current fiscal year.
About CBIZ
(
Free Report)
CBIZ, Inc provides financial, insurance, and advisory services in the United States and Canada. It operates through Financial Services, Benefits and Insurance Services, and National Practices segments. The Financial Services segment offers accounting and tax, financial advisory, valuation, risk and advisory, and government healthcare consulting services.
Featured Articles

Before you consider CBIZ, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CBIZ wasn't on the list.
While CBIZ currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.